Angel Montero Luis

[Angel Montero Luis @Oncoangel]

📢Our last paper providing practical tips&tricks to support low-dose radiotherapy for non-malignant disorders:
Who is LDRT for?
Why implement LDRT?
How does LDRT work?
Is LDRT safe?
What resources do I need?
#ldrt #radonc @RadioterapiaHM@HMHOSPITALES https://t.co/ogjpIKFu4r

[Angel Montero Luis @Oncoangel]

Hoy ha fallecido el Dr. Alejandro de la Torre Tomás, uno de los mejores oncólogos de España, una excelente persona, un gran maestro para muchos, que aprendimos con él y de él el arte de la Medicina, y sobre todo un amigo. ¡Gracias por tanto, Alejandro! D.E.P. #radonc

[Angel Montero Luis @Oncoangel]

@subatomicdoc @BetterCallBenni @jryckman3 @SprakerMDPhD @JJCaudell @NiuSanford @NEJM That will be a great point! Ready to collaborate. At your disposal, Matt!

[Angel Montero Luis @Oncoangel]

The role of radiation therapy in the multidisciplinary management of male breast cancer: a systematic review and meta-analysis #radonc #bcsm https://t.co/wC8jvUgoRz

[SBRT memes for hypofractionated teens @sbrtmemes]

When you get asked about your treatment plan and you cite your own paper
#radonc
#sbrtmemesetal2024

[SEOR.es @SEOR_ESP]

La Dra. @Mamen_RubioR, presidenta de @SEOR_ESP, y el Dr. Germán Juan Rijo, presidente del Comité Organizador del Congreso, nos presentan el #CongresoSEOR24 via @IMMedicoHosp
https://t.co/HYQniq7w2I

[Jennifer Le Guévelou @JennKa12]

💥 Consensus GFRU

✨ Delineation of urinary organs-at risk for prostate cancer external beam radiotherapy

🌪️ Let’s reshape our vision of urinary toxicity and implement new dose-constraints within prospective trials….

https://t.co/hmHHpHq4vK

[Vivian Tan MD @drviviantan]

🔥Hot off the press @EurUrolOncol

IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc

https://t.co/hogLg40zkk

Thankful for mentors @_ShankarSiva
@DrAlexLouie @DrCorreaRO

[Join Y. Luh, MD (he/him/dude/他) @j_luh]

#bcsm #radonc

5 yrs of endocrine therapy with all the side effects vs 5 to 15 fx #XRT

What would fully informed patients choose?

[Paolo Tarantino @PTarantinoMD]

What is HER2 « ultralow » breast cancer, and why should you care?

A thread:

[ECOG-ACRIN Cancer Research Group @eaonc]

Imagine a future where #breastcancer screening is tailored to your individual risk factors. The TMIST trial could help make this possible. Learn more: https://t.co/O3fHpNLruK #bcsm #TMIST4BC cc: @RadiologyACR @NCIprevention

[JCO Global Oncology @JCOGO_ASCO]

⚠️ Exploring the landscape of risk-reducing measures & cascade testing among carriers of #BreastCancer-associated #germline variants in #Mexico 🇲🇽 sheds light on crucial challenges. Check this article for more details: https://t.co/8A6npijJIA #BCSM #GlobalOnc

[NCI Cancer Stats @NCICancerStats]

Non-Hispanic Black women have the highest rate of new HR-/HER2- #BreastCancer cases. The most common subtype across all racial and ethnic groups is HR+/HER2-. Visit our Cancer Stat Facts sheet to learn more: https://t.co/AmMpk4cX5V #BCSM

[Jeff Ryckman @jryckman3]

Discover more and join the conversation! 👉 https://t.co/0A7GrPOhNz

#radonc #SABRPower #akaSBRT #SBRT #AlphabetSoup

#adcsm #LCSM #KCSM #CRCSM #PCSM #AMSM #PancSM #hpbcsm #scmsm #sarcoma

[eContour @eContourRadOnc]

Shameless plug!

📢👂#radonc residents (especially those new PGY-2s!) -- check out our website for your pick of

✅contoured cases
✅OARs
✅treatment paradigms
✅contouring atlases
✅all the clinical pearls
✅... and SOO much more!

https://t.co/0fcpczK7T0

[Angel Montero Luis @Oncoangel]

Hypofractionated Radiation Therapy is safe, effective, and beneficial, and yet underutilized... #radonc https://t.co/qb6a2fY6DY

[Drew Moghanaki @DrewMoghanaki]

A research team at @MoffittRadOnc led by @tom_dilling publishes the largest series evaluating Surgery and SBRT for stage I SCLC. The report contains valuable data about adjuvant chemotherapy and PCI for this population. #radonc https://t.co/cKKBJfqwnC

[RANZCR @RANZCRcollege]

SABR Power. @TargetingCancer shines a light on stereotactic ablative body radiotherapy in the latest edition of Inside News.

Read the story here:
https://t.co/eHiFlita3a

#RANZCR #TargetingCancer

[Bobby Koneru, MD @KoneruMd]

Credit: radonc_memes on instagram

#radonc

[Angel Montero Luis @Monthy_A]

Feasibility and Safety of the “One-Week Breast Radiation Therapy” Program #radonc #bcsm https://t.co/OhcLLWQnMI